MB

Mira Bhavin Mehta

Active Director Managing Director DIN 01902831
DIN 01902831 First appointment Mar 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Mar 2008
Shareholding value •••• Premium profile

About Mira Bhavin Mehta

Data last updated:

Mira Bhavin Mehta is a Managing Director at Kilitch Drugs (India) Limited (since 2014), Director at Monarchy Healthserve Private Limited (since 2017) and Director at Kilitch Company (Pharma) Limited (since 2020), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Packaging. The 3 current companies with reported revenue have a combined latest revenue of ₹210 Cr; the largest is Kilitch Drugs (India) Limited at ₹209 Cr (FY 2025). Earlier, Mira Bhavin Mehta was a Director at Eye Kare Kilitch Limited (2012–2016) and Director at Nbz It Solutions Limited (from 2008).

DIN 01902831
Primary Designation Managing Director
Industry Pharma
First Appointment 14 Mar 2008
Oldest Company Age 43 yrs
Largest company Kilitch Drugs (India) Limited · ₹209 Cr (FY 2025)
Combined revenue ₹210 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kilitch Drugs (India) Limited L24239MH1992PLC066718
Managing Director30 Sep 20141992₹209 Cr (FY 2025)Active
Monarchy Healthserve Private Limited U74999MH2007PTC167204
Director24 Mar 20172007₹14.6 Lakh (FY 2021)Active
Kilitch Company (Pharma) Limited U24230MH1983PLC030632
Director26 Dec 20201983₹1.9 Lakh (FY 2023)Active
Partner15 Feb 20192013Active
Partner11 Mar 20132013Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eye Kare Kilitch Limited U24297MH2009PLC198224
Director25 May 20122009Active
Nbz It Solutions Limited U72900MH2008PLC180124
Director14 Mar 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arham Neeta Realities Llp
Nbz Healthcare Llp
Kilitch Company (Pharma) Limited
Monarchy Healthserve Private Limited
Premium access

Shareholding and investment profile for Mira Bhavin Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mira Bhavin Mehta

Mira Bhavin Mehta currently holds 5 directorships: Kilitch Drugs (India) Limited (Managing Director, since 30 Sep 2014, revenue ₹209 Cr (FY 2025)); Monarchy Healthserve Private Limited (Director, since 24 Mar 2017, revenue ₹14.6 Lakh (FY 2021)); Kilitch Company (Pharma) Limited (Director, since 26 Dec 2020, revenue ₹1.9 Lakh (FY 2023)); Nbz Healthcare Llp (Partner, since 15 Feb 2019); Arham Neeta Realities Llp (Partner, since 11 Mar 2013).

Mira Bhavin Mehta was first appointed on 14 Mar 2008 as Director at Nbz It Solutions Limited. The most recent appointment on record is 26 Dec 2020 at Kilitch Company (Pharma) Limited.

The 3 current companies of Mira Bhavin Mehta that report revenue have a combined latest revenue of ₹210 Cr: Kilitch Drugs (India) Limited ₹209 Cr (FY 2025); Monarchy Healthserve Private Limited ₹14.6 Lakh (FY 2021); Kilitch Company (Pharma) Limited ₹1.9 Lakh (FY 2023).

Mira Bhavin Mehta held 2 earlier board appointments: Eye Kare Kilitch Limited (Director, 25 May 2012 to 07 Apr 2016); Nbz It Solutions Limited (Director, from 14 Mar 2008).

The current boards of Mira Bhavin Mehta's companies include Bhavin Mukund Mehta (Kilitch Drugs (India) Limited), Dipen Jayantilal Jain (Kilitch Drugs (India) Limited), Mukund Prataprai Mehta (Kilitch Drugs (India) Limited), Pushpa Nyoupane (Kilitch Drugs (India) Limited), Sunil Sureshji Jain (Kilitch Drugs (India) Limited), Vasudev Krishnamurti (Kilitch Drugs (India) Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available